Melanie Gloria - Nov 20, 2025 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Operating Officer
Signature
/s/ Tiago Girao, attorney-in-fact for Melanie Gloria
Stock symbol
IMVT
Transactions as of
Nov 20, 2025
Transactions value $
-$298,237
Form type
4
Date filed
11/21/2025, 04:24 PM
Previous filing
Apr 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gloria Melanie Chief Operating Officer C/O IMMUNOVANT, INC., 320 W 37TH STREET, 6TH FLOOR, NEW YORK /s/ Tiago Girao, attorney-in-fact for Melanie Gloria 2025-11-21 0001973838

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Sale -$241K -10.3K -5.51% $23.54 176K Nov 20, 2025 Direct F1, F2
transaction IMVT Common Stock Sale -$56.9K -2.38K -1.35% $23.97 174K Nov 20, 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 27,489 of these RSUs vested on November 18, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.93 - $23.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.93 - $24.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney